Abstract:Host immunity ensures protection against a foreign intrusion having the potential to disrupt the physiological balances of the host. Innate immunity is a first line of defense and is instrumental in the development of appropriate defense against infection. However, overactivation of innate immune components results in immunopathogenesis. The family of proteins, known as complement protein, constitute complement system and participates in development of inflammation and elimination of the target pathogenic microbial cells by specialized immunological processes. Another family of proteins involved in innate immune defense are anti-microbial proteins or peptides. These proteins or peptides either directly act on target cells or facilitate elimination through recruitment of appropriate immune cells. The cellular components of innate immunity such as macrophages, dendritic cells and natural killer cells are first responders to any foreign intruders and initiate a sequence of primary responses including phagocytosis, or direct killing of modified self (tumor or cancerous) cells or inducing inflammation via various inflammatory mediator through complex cellular signaling pathways. A specialized immune cell known as innate lymphoid cells of lymphoid lineage playing an important role on mucosal surfaces in immune regulation to maintain immune homeostasis. This issue of International Reviews of Immunology focuses on articles discussing cellular and humoral components in development of disease and manipulation of innate immune signaling pathways for the development of possible immunotherapeutics (Figure 1).

Sentinels of innate immunity in disease pathogenesis and development of therapeutics